Cell Wall Synthesis Inhibitors Notes PDF
Document Details
Uploaded by EntertainingFunction6223
Tags
Summary
This document provides notes on cell wall synthesis inhibitors, such as penicillins, cephalosporins, carbapenems, and monobactams. It describes their mechanisms of action, resistance mechanisms, and therapeutic uses. The document is suitable for undergraduate-level students studying medicine or related fields.
Full Transcript
Cell Wall Synthesis Inhibitors Penicillins: Include various types like Penicillin G, Penicillin V, and Amoxicillin. Primarily effective against gram-positive bacteria. Cephalosporins: Antibiotics derived from Cephalosporium, with generations ranging from 1st to 5th Carbapenems: Broad-spectrum antib...
Cell Wall Synthesis Inhibitors Penicillins: Include various types like Penicillin G, Penicillin V, and Amoxicillin. Primarily effective against gram-positive bacteria. Cephalosporins: Antibiotics derived from Cephalosporium, with generations ranging from 1st to 5th Carbapenems: Broad-spectrum antibiotics effective against both gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa. Monobactams: Like Aztreonam, these antibiotics target gram- negative bacteria such as Pseudomonas aeruginosa. Mechanism of Action: Beta-lactam antibiotics disrupt bacterial cell wall synthesis by inhibiting penicillin-binding proteins (PBPs), leading to bacterial cell lysis. Bacterial Resistance: Resistance mechanisms include beta- lactamase activity, alteration of PBPs, and reduced drug permeability. Beta-Lactamase Inhibitors: Clavulanic acid, Sulbactam, and Tazobactam are examples that protect penicillins from inactivation by enzymes. Therapeutic Uses: Penicillins are used for various infections like skin and soft tissue infections, while cephalosporins are used for respiratory, urinary, and soft tissue infections. Adverse Effects: Both penicillins and cephalosporins can cause hypersensitivity reactions and gastrointestinal disturbances. Carbapenems and Monobactams: Carbapenems are potent broad-spectrum antibiotics, while Monobactams like Aztreonam target gram-negative bacteria.